Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |